ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENTEmployment Transition Agreement • May 7th, 2015 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • California
This Executive Employment Transition Agreement (“Transition Agreement”), replaces and supersedes the employment letter agreement of December 21, 1998 (the “Employment Agreement”) and all other employment or employment-related agreements or commitments entered into prior to the Effective Date of this Transition Agreement (collectively, with the Employment Agreement, the “Prior Agreements”), by and among ACADIA Pharmaceuticals Inc., a Delaware corporation, (the “Company”), and Uli Hacksell, Ph.D. (the “Executive”). This Transition Agreement shall become effective on the “Effective Date” specified in Section 7 below.
March 20, 2015 Stephen R. Davis Interim CEO Executive Vice President, Chief Financial Officer and Chief Business Officer RE: Retention Bonus Agreement Dear Steve:Acadia Pharmaceuticals Inc • May 7th, 2015 • Pharmaceutical preparations
As an incentive for you to continue to contribute your efforts, talents and services to ACADIA Pharmaceuticals Inc. (the “Company”), the Company is pleased to announce your eligibility to earn a one-time retention bonus payment in the amount of $100,000 (the “Retention Bonus”), less applicable taxes and withholdings under the terms and conditions set forth in this letter agreement (the “Agreement”).
